Patient-reported outcome measures in phase III trials of LY2963016 insulin glargine and reference insulin glargine products: ELEMENT 1 and ELEMENT 2

Authors:

Perez-Nieves M, K Pollom R, Duan R, Kalirai S, Delozier A, Kaushik P and Ilag L

Publication type:

Journal article

Publication name:

Generics and Biosimilars Initiative Journal

Citation:

Perez-Nieves M, K Pollom R, Duan R, Kalirai S, Delozier A, Kaushik P and Ilag L. Patient-reported outcome measures in phase III trials of LY2963016 insulin glargine and reference insulin glargine products: ELEMENT 1 and ELEMENT 2. GaBI Journal. 2018; 7(2):56-62.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies